BUPHENYL (Horizon Pharma, Inc.)
Welcome to the PulseAid listing for the BUPHENYL drug offered from Horizon Pharma, Inc.. This Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Horizon Pharma, Inc. |
| NON-PROPRIETARY NAME: | sodium phenylbutyrate |
| SUBSTANCE NAME: | SODIUM PHENYLBUTYRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-05-13 |
| END MARKETING DATE: | 0000-00-00 |
BUPHENYL HUMAN PRESCRIPTION DRUG Details:
| Item Description | BUPHENYL from Horizon Pharma, Inc. |
| LABELER NAME: | Horizon Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 1996-05-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 75987-060_8b23789a-d8e5-4bdf-8a01-25b7ecd1d51d |
| PRODUCT NDC: | 75987-060 |
| APPLICATION NUMBER: | NDA020572 |
Other SODIUM PHENYLBUTYRATE Pharmaceutical Manufacturers / Labelers:
